The Pursuit of Prevention of Renal failure in an imperfect world-Is it possible in the 21 st century? By: Baskar, WDHB, Renal Service Auckland New Zealand.

Slides:



Advertisements
Similar presentations
Risk Stratification in Renal Care Mary Jane McKendry Vice President, Operations Fresenius Disease Management Optimal Renal Care.
Advertisements

The National Kidney Foundations Kidney Early Evaluation Program TM The National Kidney Foundations Kidney Early Evaluation Program TM Essex-Passaic Wellness.
Lysaght, J Am Soc Nephrol, 2002 Number of patients worldwide treated with chronic dialysis from 1990 to ,000 1,490,000 2,500,000.
DIABETIC NEPHROPATHY MAY 2013 DR RAMESH B NAIK FRCP.
ESRD Registry Committee, Korean Society of Nephrology*
Renal Replacement Therapy: What the PCP Needs to Know.
What is World Kidney Day? Worldwide campaign celebrated every year on the second Thursday of March [12 March 2015] A joint partnership between the International.
SLOW- COOKING THE BEANS “OR, HOW TO STOP WORRYING AND APPLY SOME LOVE TO THE KIDNEYS” AN APPROACH TO CKD SARA KATE LEVIN, MD JANUARY 2014.
General Practice Workshop This workshop was conceived and developed by Kidney Health Australia’s Kidney Check Australia Taskforce with particular thanks.
Foundation Civilization Day, Foundation Week May 8-14, 2006 Anatolia Kidney Foundation Day, May 8, 2006 Prof. Dr. Ayla SAN THE IMPORTANCE OF 9 MARCH WORLD.
DIABETES AND THE KIDNEYS
CKD In Primary Care Dr Mohammed Javid.
National Institute for Health and Clinical Excellence.
Chronic Kidney Disease NICE Guidelines 2008 Dr Jennifer Kuo Dr Naeema Rashid Dr Shamita Das.
1 Prediabetes Comorbidities and Complications. 2 Common Comorbidities of Prediabetes Obesity CVD Dyslipidemia Hypertension Renal failure Cancer Sleep.
Hypertension and The Kidney Update: Clinical Trials Paul J. Scheel, Jr., M.D. Director, Division of Nephrology The Johns Hopkins University School of Medicine.
Absolute cardiovascular disease risk Assessment and Early Intervention Dr Michael Tam Lecturer in Primary Care
Cardiovascular Disease Prevention in Clinical Practice – The National Coordinator Dr Siobhan Jennings, Consultant in Public Health Medicine National Coordinator.
Dr. Sevil Huseynova World Health Organization
Lesley Stevens MD Tufts-New England Medical Center
Facts and Fiction about Type 2 Diabetes Michael L. Parchman, MD Department of Family & Community Medicine September 2004.
APPENDIX 1. D-1 New cases of diagnosed diabetes D-2.1 All cause mortality* D-2.2 Cardiovascular disease deaths* D-3 Diabetes death rate, multiple cause.
Clinical Update on the JNC 7/8 Hypertension Guidelines
Early Detection and Prevention of Renal Failure Linda Fried, MD, MPH.
Section 4: Managing progression of CKD. Glomerulosclerosis Reduction in number of functioning glomeruli Increased blood flow to remaining nephrons Intraglomerular.
RENAL DISEASE IN DIABETES
EPIDEMIOLOGY Epidemiology of chronic kidney injury, including prevalence and prognosis in various community groups. Screening of populations for kidney.
Source: Site Name and Year IHS Diabetes Audit Diabetes Health Status Report ______Site Name_________ Health Outcomes and Care Given to Patients with Diabetes.
December Cardiac Rehabilitation Are you or someone you know missing the benefits of Cardiac Rehabilitation?
Rapid E clinical guidance in the management of Type 2 diabetes New Zealand Guidelines Group.
British Journal of Healthcare Assistants The HCAs Role in Diabetes Management in Primary Care Linda Goldie Clinical Director Primary Care Training Centre.
SM Gatmiri, MD, Nephrologist Imam Khomeini Hospital,
If I had Chronic Kidney Disease: What would I want my Doctor to Know….. Liam Plant Department of Renal Medicine, Cork University Hospital Department of.
Hypertension the Community - Overview HYPERTENSION IN THE COMMUNITY: OVERVIEW.
New Zealand Cardiology Wards and Adventures Taylor Myers Locke.
NICE GUIDELINES HYPERTENSION Masroor Syed. Latest Issue June 2006 Evidence Based uickrefguide.pdf
Definitions and classification of office blood pressure levels (mmHg) Modified by ESC Guidelines 2013 CARDIOcheckAPP.
10/5/2015. Hypertension GuidelinesDate JNC JNC JNC NICE Guidelines 2011 ESC / ESH Hypertension Guidelines ESC Guideline2007.
Irbesartan Diabetic Nephropathy Trial (IDNT) Collaborative Study Group N Eng J Med 345: , 2001 Edmund J. Lewis, M.D. Muehrcke Family Professor of.
Section 5: Configuration of healthcare to manage CKD.
10 Points to Remember on An Effective Approach to High Blood Pressure ControlAn Effective Approach to High Blood Pressure Control Summary Prepared by Debabrata.
Hypertension & diabetes: new guidelines Janice Douglas, MD Case Western University Cleveland, OH George L Bakris, MD Director of the Hypertension/Clinical.
Dr M Sivalingam Renal Unit, Lister Hospital, Stevenage.
© ANZDATA Registry PEADIATRIC CHAPTER CHAPTER 11.
Cardiovascular Disease Healthy Kansans 2010 Steering Committee Meeting April 22, 2005.
Chapter 10 Cancer 2014 ANZDATA Registry 37th Annual Report Data to 31-Dec-2013 ANZDATA gratefully acknowledges the contributions of the Cancer Working.
Chapter 5 Peritoneal Dialysis 2014 ANZDATA Registry 37th Annual Report Data to 31-Dec-2013 ANZDATA gratefully acknowledges the contributions of the Peritoneal.
Chapter 12 End Stage Kidney Disease among Indigenous Peoples of Australia and New Zealand 2014 ANZDATA Registry 37th Annual Report Data to 31-Dec-2013.
Hypertension Family Medicine Specialist CME October 15-17, 2012 Pakse.
In The name of God. Diabetes epidemiology: Reflecting your clinic?
What is PD2010_023 Policy Directive from NSW DOH, 15th April 2010
Chronic Kidney Disease (CKD) Healthy Kansans 2010.
References 1.Buse JB, Ginsberg HN, Bakris GL, et al. Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement.
PUTTING PREVENTION FIRST Vascular Checks/ NHS Health Checks.
NHS Health Check programme An opportunity to engage 15 million people to live well for longer Louise Cleaver National Programme Support Manager.
Am J Kidney Dis. 2014;63(6): R3 박세정 /prof. 이태원 Comparative Effectiveness of Early Versus Conventional Timing of Dialysis Initiation in Advanced.
Chronic Kidney Disease (CKD) Dr. Sham Sunder. Now we know why the titanic sank !! < 0.5 % 5- 10%
Cardiovascular Disease and Antihypertensives The RENAAL Trial Reference Brunner BM, and the RENAAL study group. Effects of losartan on renal and cardiovascular.
Dr John Cox Diabetes in Primary Care Conference Cork
Nephrology Journal Club The SPRINT Trial Parker Gregg
Section 4: Managing progression of CKD
Hypertension November 2016
SPECIALIST NURSE SUPPORT IN PRIMARY CARE
Presentation for Community Leadership
Section 5: Configuration of healthcare to manage CKD
Presentation for Community Members
Presentation for Health Care Staff & Health Stakeholders
Presentation for Community Leadership
Beth Wallace, BSN, RN-BC, FNP-S Fairfield University Summer 2010
Hypertension November 2016
Presentation transcript:

The Pursuit of Prevention of Renal failure in an imperfect world-Is it possible in the 21 st century? By: Baskar, WDHB, Renal Service Auckland New Zealand Presented at : “4 th International Conference on Nephrology and Therapeutics” – Baltimore USA

International Society of Nephrology (ISN) and the International Federation of Kidney Foundations (IFKF). World Kidney Day is a joint initiative between ISN & IFKF. World Kidney Day started in 2006 and has not stopped growing ever since. They didn’t do this for fun Its not a single day prevention programme

Diabetes NZ 2014 Diabetes in New Zealand 257,776 New Zealanders have been diagnosed with diabetes Every day, around 50 more people are diagnosed-that’s 2 every hour Diabetes currently costs the health system around $600 million per year Those most at risk of diabetes are Maori, Pacific Islanders and South Asians Diabetes is a major contributors to heart disease, stroke, and kidney disease

Source : ANZDATA REGISTRY 2014 Diabetic status at end of year

Dialysis Numbers - ANZDATA

Method and location of dialysis Australia & New Zealand, Source : ANZDATA REGISTRY 2014 AustraliaNew Zealand

Incident counts (USRDS), by modality

Causes of ESRD in Australia & New Zealand Source :

Causes of ESRD in NZ. These are the diseases which can be prevented Disease New Zealand Glomerulonephritis 125 (21%)111 (22%)114 (24%)105 (20%) Analgesic Nephropathy 2 (0%) 5 (1%)4 (1%) Ploycystic Kidney Disease 34 (6%)18 (3%)28 (6%)27 (%) Reflux 9 (2%)8 (2%)9 (2%)8 (2%) Hypertension 62 (11%)58 (11%)51 (11%)48 (9%) Diabetic Nephropathy 279 (48%)260 (50%)204 (42%)249 (49%) Miscellaneous 54 (9%)41 (8%)53 (11%)57 (11%) Uncertain Diagnosis 19 (3%)17 (3%)21 (4%)15 (3%) NZ Total Source :

Diabetic Nephropathy Source : Google images Disease New Zealand Diabetic Nephropathy 279 (48%)260 (50%)204 (42%)249 (49%)

Nephrosclerosis - (Hypertension) Source : Google images Disease New Zealand Hypertension 62 (11%)58 (11%)51 (11%)48 (9%)

Complications of Hypertension: End-Organ Damage Chobanian AV, et al. JAMA. 2003;289: Peripheral Vascular Disease Renal Failure, Proteinuria LVH, CHD, CHF Hemorrhage, Stroke Retinopathy CHD = coronary heart disease CHF = congestive heart failure LVH = left ventricular hypertrophy Hypertension

Polycystic Kidney Disease Source : Google images Disease New Zealand Ploycystic Kidney Disease 34 (6%)18 (3%)28 (6%)27 (%)

Reflux Nephropathy nephrosclerosis Source : Google images Disease New Zealand Reflux 9 (2%)8 (2%)9 (2%)8 (2%)

Important work done by Kidney Health New Zealand Education Manager, Carmel Gregan-Ford and KHNZ Team: Community education targeting groups at high risk of kidney disease. Support for education of kidney health professionals. Kidney Awareness Week and World Kidney Day activities. KHNZ, funded by Ministry of Health, has developed 15 web-based patient information resources – 5 for children and their families Working with other groups Diabetes New Zealand, Christchurch & Auckland Diabetes Societies.

Guide to CKD management in general practice Most CKD is managed in primary care. Most people with CKD do not know they have the condition. Groups at high risk of CKD can be screened with simple blood and urine tests. KHNZ has developed a GP Guide for the Management of Chronic kidney Disease16 and a number of DHBs have guidelines for patient referral for specialist care. Source : Kidney Health NZ

Goals for best practice in managing CKD Those people with, or at risk of, progressive CKD are identified and effectively managed. Cardiovascular risk is reduced through optimal lifestyle modification, smoking cessation, blood pressure control, glycaemic control, and use of statins. Effective blood pressure control reduces albuminuria and slows the rate of decline of eGFR in many patients. The incidence and prevalence of CVD, progressive CKD and ESKD, and their associated morbidity and mortality rates, fall over time. Source : Ministry of Health

A community-based model of care improves blood pressure control and delays progression of proteinuria, left ventricular hypertrophy and diastolic dysfunction in Māori and Pacific patients with type 2 diabetes and chronic kidney disease: a randomized controlled trial

Maori, Pacific People, and Renal Failure Diabetes as a primary cause of new ESRD Maori 63% Pacific 65% European 17% Compared to people of European origin The diabetes prevalence in Maori 2.5 x ESRD incidence in Maori secondary to Diabetes is 13.6 x and GN is 1.9 x ESRD incidence in Pacific people secondary to diabetes is 14.7 x and GN 2.3 x Ministry of Health. Tatau Kahukura: Maori health Chartbook.2006 ANZDATA

DEFEND Study All had baseline and 1 year evaluation All patients had standard GP, Diabetic clinic and Renal Clinic care Half of the patients were randomised to the Community Care group. They had monthly home visits by a Health Care Assistant (polynesian) to check BP and compliance and in concert with the study nurse and Research Fellow change meds according to a simple algorithm (single daily dosing –ACEi/diuretic/CCB/other- doses optimised) Source :April 6th Nephrology Dialysis Transplantation 2010

DEFEND Source :April 6th Nephrology Dialysis Transplantation 2010

Summary of the study Frequent home visiting led to improved BP control with associated reduction in proteinuria and stabilisation of LV mass This occurred because of improved medication prescribing and adherence. We could not demonstrate an effect on renal function (small numbers)

Preventive measures by Kidney Help trust Co-operated for survey 89.61% Disease known earlier 30.34% Preferred private therapy 24.60% Co-operated for treatment 78.91% Hypertension controlled to 140/ % Hb A1 C reduced 10% or more 76.79% New diabetes each year 0.32% New hypertension each year 0.55%

343, m 14, ,000 Probable number with CKD in NZ ( adapted from various sources ) 42,000* ,200

CKD Nurse Specialist in NZ Transplant Dialysis ESRD preparation Prevent Progression172:000 CKD Nurse Specialist Initiator / Injury Protein leakage, Proteinuria Locate people at Risk DIABETES. HYPERTENSION, ELDERLY, Screening High Risk Population

Solutions to our problem Education Prevention & screening in community Early detection in the community Early treatment in primary care supported by specialists Awareness in the community All renal staff must take responsibility to promote prevention.

What changes we need Television, print media and social media adds to raise awareness national wide Create Apps for awareness and prevention Free or affordable GP service for those who can ’ t afford Screening renal functions starting from the age 25. Participation in screening programs More funds should be allocated for prevention programme

Auckland Kidney Society Nora Van der Schrieck, Executive Director, Kidney Society 23 years Home haemo partner for husband Transformed a small support group into a professional organisation providing free community support for 3000 families living with kidney failure Encouraging people with CKD and their families to adopt a healthier lifestyle and avoid dialysis Partnering with a District Health Board to promote Live Kidney Donation

Acknowledgements WDHB, CEO and GM WDHB, Renal service CNM WDHB, Nephrologist’s and all staff John Collins, Associate Prof Nephrology Kidney Health NZ, Education Manager and team Auckland Kidney society, Executive Director Diabetes NZ NZBDP Organizing committee of - 4th international conference on Nephrology Thank my family

Treating Renal failure in NZ is the state of the art But Pursuit of prevention of renal failure in 21 st century is the art of Possible